- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/42 - Nitrogen atoms attached in position 4
Patent holdings for IPC class C07D 215/42
Total number of patents in this class: 285
10-year publication summary
|
16
|
17
|
15
|
21
|
20
|
24
|
15
|
14
|
10
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10421 |
15 |
| Abivax | 119 |
10 |
| Institut Curie | 582 |
10 |
| Universite de Montpellier | 986 |
9 |
| Janssen Pharmaceutica N.V. | 3395 |
6 |
| The Regents of the University of California | 19898 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| The Board of Regents of the University of Texas System | 2204 |
5 |
| H. Lundbeck A/S | 1247 |
5 |
| Pharma Cinq, LLC | 60 |
5 |
| Bristol-myers Squibb Company | 4878 |
4 |
| Takeda Pharmaceutical Company Limited | 2714 |
4 |
| Atengen, Inc. | 8 |
4 |
| Allergan, Inc. | 2349 |
3 |
| Children's Medical Center Corporation | 1866 |
3 |
| Merial, Inc. | 220 |
3 |
| Ontario Institute for Cancer Research (oicr) | 84 |
3 |
| The Scripps Research Institute | 1346 |
3 |
| St. Jude Children's Research Hospital | 243 |
3 |
| University of Louisville Research Foundation, Inc. | 719 |
3 |
| Other owners | 177 |